41 Photos and videos
We are recruiting: ERC- and DFG-funded PhD positions in Tumor Biology (Kiel, Germany). We look forward to your application!
3
11
688
Wolf Lab for Tumor Biochemistry retweeted
26 Nov 2024
Out now: Our collaborative #Golgi #glycotime story, which shows (i) that B4GALT5, a Golgi enzyme, is subject to M6P tagging and (ii) that GOLPH3/GOLPH3L stabilize LYSET and the GlcNAc-phosphotranferase complex and thus are crucial to cellular M6P tagging. tinyurl.com/jkv26nhh

2
2
357
Congratulations @_MarkusVogt for delivering a superb PhD defense!!!🍾🥂
2
1
15
673
Wolf Lab for Tumor Biochemistry retweeted
I have written a concise review on chromatin transcription as part of the @JMolBiol special issue on transcription elongation. Check it out! authors.elsevier.com/sd/arti…
43
205
13,297
We congratulate Michaela Reissland and the whole team in Markus Diefenbacher's lab on their new paper in Oncogene. In the study, they were able to demonstrate the role of USP10 in Wnt signalling in colorectal cancer models. Thank you for the opportunity to contribute.
USP10 emerges as a unique therapeutic target in APC-truncated #ColorectalCancer 🔬nature.com/articles/s41388-0… @DiefenbacherL #OpenAccess
1
5
424
Congratulations, Lorenz!
20 Sep 2024
PhDone ✅ @EingLorenz finally defended his defense. After his PhD in the @_WolfLab he is now working as a Postdoc in our Lab! Fantastic defense and as always a good party afterwards!
6
306
Wolf Lab for Tumor Biochemistry retweeted
13 Aug 2024
#GUTAbstract by @_MarkusVogt @_WolfLab et al on "Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2" via bit.ly/3SNQbX0 Paper: bit.ly/3M5SqkW @DiefenbacherL @NevenkaDudvars1 #Pancreas #PancreaticCancer
1
6
10
1,396
Graduate students and postdocs interested in PROTACs and Glues: Register for the AEK workshop November 4-6 in Berlin with outstanding international speakers: aek-conferences.org/autumnsc…
1
1
517
Many thanks to the press office of Kiel University for the press release about our new paper in GUT: uni-kiel.de/de/detailansicht…
4
297
We are recruiting: ERC- and DFG-funded PhD positions in Tumor Biology (Kiel, Germany). We look forward to your application!
4
4
566
Congratulations to all the authors on their great work!
More than happy to finally see our paper out in @NatureCellBio! We de-orphanized MFSD1 as a lysosomal dipeptide uniporter. Fantastic work of @Kathaschnatta, @OceaneGuelle, @AllUNeedIsLoew and Bruno Gasnier: nature.com/articles/s41556-0… so nice to see the structure of MFSD1&GLMP!
254
Acute degradation of RUVBL1 in transplanted PDAC tumors via the auxin-inducible degron (AID) system resulted in complete tumor regression in immunocompetent mice which was preceded by infiltration with CD3-positive immune cells.
2
1
260
Thereby, targeting of RUVBL1/2 transforms PDAC into an immunologically “hot” tumor, responsive to immunotherapy. In summary, our work identified the MYC-RUVBL1/2 axis as a druggable vulnerability of MYC-driven cancer.
1
1
220
Congratulations to @MV4_11, @NevenkaDudvars1 and the other contributing members of @_WolfLab and many thanks to our collaborators @MYCGyvers, @seyvos, @WiegeringLab, @DiefenbacherL, @GeorgGasteiger, Florian Erhard, Stefan Knapp and Dieter Saur.
1
5
273
We investigated the possibility of targeting the prominent oncogene MYC via its binding partners. We prioritized MYC binding partners by genetic screens in PDAC cells in culture and in immunocompetent mice.
1
1
226
RUVBL1/2 interacts directly with MYC and gets recruited to chromatin by MYC, where it is required to establish oncogenic and immune-evasive gene expression.
1
173
While PDAC dependencies in cell culture followed public essentiality data of the @CancerDepMap portal, dependencies on MYC binding partners were reduced in vivo. Among the most essential MYC binding partners in vivo were RUVBL1 and RUVBL2 which form a AAA ATPase complex.
1
181